{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T13:47:08Z","timestamp":1747921628485,"version":"3.37.3"},"reference-count":21,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":354,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN275201200427P"],"award-info":[{"award-number":["HHSN275201200427P"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001285","name":"Pacific Institute for Research and Evaluation","doi-asserted-by":"crossref","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/100001285","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/add.12700","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T13:42:11Z","timestamp":1407332531000},"page":"2044-2052","source":"Crossref","is-referenced-by-count":4,"title":["What happens when people discontinue taking medications? Lessons from COMBINE"],"prefix":"10.1111","volume":"109","author":[{"given":"Robert L.","family":"Stout","sequence":"first","affiliation":[{"name":"Decision Sciences Institute; Pacific Institute for Research and Evaluation; Pawtucket RI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan M.","family":"Braciszewski","sequence":"additional","affiliation":[{"name":"Decision Sciences Institute; Pacific Institute for Research and Evaluation; Pawtucket RI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi Sabina","family":"Subbaraman","sequence":"additional","affiliation":[{"name":"Alcohol Research Group; University of California at Berkeley School of Public Health; Berkeley CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry R.","family":"Kranzler","sequence":"additional","affiliation":[{"name":"University of Pennsylvania; Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie S.","family":"O'Malley","sequence":"additional","affiliation":[{"name":"Yale University; New Haven CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Falk","sequence":"additional","affiliation":[{"name":"Division of Treatment and Recovery Research; National Institute on Alcohol Abuse and Alcoholism; Rockville MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ACTIVE group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,12]]},"reference":[{"key":"10.1111\/add.12700-BIB0001|add12700-cit-0001","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/epirev\/24.1.26","article-title":"Analysis of randomized controlled trials","volume":"24","author":"Peduzzi","year":"2002","journal-title":"Epidemiol Rev"},{"key":"10.1111\/add.12700-BIB0002|add12700-cit-0002","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/alcalc\/agt134","article-title":"Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials","volume":"48","author":"Gurvich","year":"2013","journal-title":"Alcohol Alcohol"},{"key":"10.1111\/add.12700-BIB0003|add12700-cit-0003","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jsat.2010.06.002","article-title":"Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence","volume":"39","author":"Koeter","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"10.1111\/add.12700-BIB0004|add12700-cit-0004","first-page":"140","volume-title":"Contingency Management in the Treatment of Substance Use Disorders: A Science-Based Treatment Innovation","author":"Rounsaville","year":"2008"},{"key":"10.1111\/add.12700-BIB0005|add12700-cit-0005","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.15288\/jsad.2011.72.1012","article-title":"Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review","volume":"72","author":"Swift","year":"2011","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1111\/add.12700-BIB0006|add12700-cit-0006","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1360-0443.2004.00884.x","article-title":"Adherence to pharmacotherapy in patients with alcohol and opioid dependence","volume":"99","author":"Weiss","year":"2004","journal-title":"Addiction"},{"key":"10.1111\/add.12700-BIB0007|add12700-cit-0007","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s002130050126","article-title":"Ritanserin in the treatment of alcohol dependence-a multi-center clinical trial","volume":"128","author":"Johnson","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/add.12700-BIB0008|add12700-cit-0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1530-0277.1996.tb01036.x","article-title":"Elevated rates of early discontinuation from pharmacotherapy trials in alcoholics and drug abusers","volume":"20","author":"Kranzler","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/add.12700-BIB0009|add12700-cit-0009","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.addbeh.2013.01.024","article-title":"Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response","volume":"38","author":"Gueorguieva","year":"2013","journal-title":"Addict Behav"},{"key":"10.1111\/add.12700-BIB0010|add12700-cit-0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1300\/J069v19n01_06","article-title":"Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients","volume":"19","author":"Pettinati","year":"2000","journal-title":"J Addict Dis"},{"key":"10.1111\/add.12700-BIB0011|add12700-cit-0011","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1747-597X-4-2","article-title":"Stereotyping and the treatment of missing data for drug and alcohol clinical trials","volume":"4","author":"Arndt","year":"2009","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1111\/add.12700-BIB0012|add12700-cit-0012","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1530-0277.2008.00698.x","article-title":"A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention","volume":"32","author":"Oslin","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/add.12700-BIB0013|add12700-cit-0013","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/acer.12205","article-title":"Missing data in alcohol clinical trials: a comparison of methods","volume":"37","author":"Hallgren","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/add.12700-BIB0014|add12700-cit-0014","volume-title":"Form 90: A Structured Assessment Interview for Drinking and Related Behaviors","volume":"5","author":"Miller","year":"1996"},{"key":"10.1111\/add.12700-BIB0015|add12700-cit-0015","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/add.12700-BIB0016|add12700-cit-0016","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1530-0277.2003.tb02873.x","article-title":"Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods","volume":"27","author":"Combine Study Research Group","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/add.12700-BIB0017|add12700-cit-0017","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1530-0277.2003.tb02873.x","article-title":"Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study","volume":"27","author":"Combine Study Research Group","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/add.12700-BIB0018|add12700-cit-0018","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1530-0277.2008.00743.x","article-title":"Relationship between medication adherence and treatment outcomes: the COMBINE study","volume":"32","author":"Zweben","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"volume-title":"The Prevention and Treatment of Missing Data in Clinical Trials","year":"2010","author":"Panel on Handling Missing Data in Clinical Trials","key":"10.1111\/add.12700-BIB0019|add12700-cit-0019"},{"key":"10.1111\/add.12700-BIB0020|add12700-cit-0020","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1360-0443.2002.00164.x","article-title":"A multi-site study of alcohol subtypes: classification and overlap of unidimensional and multi-dimensional typologies","volume":"97","author":"Epstein","year":"2002","journal-title":"Addiction"},{"key":"10.1111\/add.12700-BIB0021|add12700-cit-0021","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/npp.2011.182","article-title":"The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders","volume":"37","author":"Anton","year":"2012","journal-title":"Neuropsychopharmacology"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.12700","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/add.12700\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:54:48Z","timestamp":1625313288000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.12700"}},"subtitle":["Discontinuing medications"],"short-title":[],"issued":{"date-parts":[[2014,9,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1111\/add.12700","relation":{},"ISSN":["0965-2140"],"issn-type":[{"type":"print","value":"0965-2140"}],"subject":[],"published":{"date-parts":[[2014,9,12]]}}}